With 15 years of investment experience in the Asia-Pacific market, he holds a Master of Finance from the University of Hong Kong and is a dual-certified CFA and FRM. He previously served as the head of Hong Kong equity research at a Hong Kong asset management firm, with extensive experience in markets such as Hong Kong, China, and Singapore. Since joining Pervaia, he has led his team in projects such as pre-IPO investments in Southeast Asian green technology and the revaluation of Hong Kong-listed biotech companies. He has accurately capitalized on cross-market opportunities under the Shanghai-Hong Kong Stock Connect program, achieving an annualized return of 22% for the Asia-Pacific portfolio he manages over the past three years.
